Make your company robust.
Sharper strategy, profitable growth, protected margins. In months, not years.
Clarity is the work. AI is the accelerator.
For CEOs and CxOs in specialty chemicals, medtech, pharma and personal care. Flat markets, eroding margins, post-M&A integration that never finished. A full-time GM's expertise at a fraction of the cost, with agentic AI as the accelerator.
One logic, end to end. Set the direction, grow the top line, protect the bottom line.
Three pillars follow the P&L. One agentic-AI engine runs across all of them, so your teams execute faster at every step.
Strategy Robustness & Decision Intelligence
Pressure-test the strategy, the organisation behind it, and the way the toughest calls get made. The direction made defensible before a single euro is spent.
Growth & IP
Unlock the top line. New applications, adjacent markets, and intellectual property turned into a commercial advantage.
Profitability Program
Protect the bottom line. Pricing, cost-to-serve, procurement, and a profit program with owners, routines and a cadence that stays.
Productivity-Augmentation
Faster execution at every step. Agents plugged onto the process exceptions where teams bridge broken systems by hand.
Strategy first. AI as the accelerator, never the entry point.
Industrial companies don't have an AI problem. They have a strategic and organisational architecture problem, and AI makes it more urgent. So the order never reverses.
A different kind of advisor.
Laurent Dumont spent 20 years taking the hard decisions from the inside. VP Business & Strategy and General Manager at Elkem Silicones, running a €500M business unit and sitting on the executive committee of a >€1B division.
Not a generic AI consultant, not a classic strategy house. A strategy and organisation architect who has run complex industrial decisions first-hand, and who now deploys agentic AI to lock in the gains.
Track record
- >€1B division turnaround, negative EBITDA to +€100M in 18 months
- Loss-making BU to +25% revenue in 12 months
- 3 cross-border acquisitions
- >€50M profit through pricing and machine learning
- Elkem, Bluestar, Rhodia, Chemtura
Where you start gaining the board's confidence, one quarter at a time.
A 30-minute call to see whether there's a fit. No pitch, a peer conversation on where the margin is hiding.